Institut Català de la Salut
[Gomez-Mariano G, Hernandez-SanMiguel E, Fernandez-Prieto M, Ramos Del Saz S, Baladrón B, Mielu LM] Genetic Diagnosis Unit, Institute for Rare Diseases Research (IIER), Institute of Health Carlos III (ISCIII), Madrid, Spain. [Sabado C] Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-03-21T09:21:38Z
2025-03-21T09:21:38Z
2025-02
Mosaicism; Next generation sequencing; Retinoblastoma
Mosaicismo; Secuenciación de nueva generación; Retinoblastoma
Mosaicisme; Seqüenciació de nova generació; Retinoblastoma
Constitutional variants in the RB1 gene predispose individuals to the development of Retinoblastoma (RB) and the occurrence of second tumors in adulthood. Detection of causal RB1 gene variants is essential to establish the genetic diagnosis and to performing familial studies and counseling. In our cohort of 579 Spanish RB patients, 15% of cases suspected to have a genetic origin remained negative after traditional Sanger sequencing and Multiplex Ligation-dependent Probe Amplification (MLPA) of RB1 gene, likely due to the possibility of mosaicism or non-coding variants. A specific next-generation sequencing (NGS) gene panel was designed to analyze the complete sequence of the RB1 gene. While many familial RB cases showed variants through Sanger and MLPA, the analysis of 65 available sporadic RB patients using the NGS gene panel identified a causative variant in an additional 6 of 26 (23%) bilateral cases and 6 of 39 (15.4%) unilateral cases. Seven of these cases exhibited different degrees of mosaicism (26%, 20%, 15.8%, 8%, 6%, 5.9% and 3%) while 5 cases had heterozygous deep intronic variants, all of them previously described in RB patients. Additional cases with suspected variants, not detected in blood but present in tumor tissue, were also analyzed using NGS PCR amplicons, and mosaicism was confirmed in other 10 sporadic cases. Altogether, the use of NGS increased the diagnostic yield, particularly for patients with sporadic RB in 10 bilateral cases and in 12 unilateral cases.
The Instituto de Salud Carlos III of Madrid has supported this work (PT23CIII/00003). We acknowledge the genomics and bioinformatics services of the Instituto de Salud Carlos III for their participation in this study. We would like to thank Belén Marugán Gómez for the illustration of the figure presented in Highlights.
Article
Published version
English
Anomalies cromosòmiques; Retina - Càncer - Diagnòstic; Retina - Càncer - Aspectes genètics; Mosaïcisme; PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation::Chromosome Aberrations::Mosaicism; DISEASES::Neoplasms::Neoplasms::Neoplasms::Neoplasms::Neoplasms by Site::Eye Neoplasms::Retinal Neoplasms::Retinoblastoma; Other subheadings::Other subheadings::/diagnosis; PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation; FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación::aberraciones cromosómicas::mosaicismo; ENFERMEDADES::neoplasias::neoplasias::neoplasias::neoplasias::neoplasias por localización::neoplasias del ojo::neoplasias de la retina::retinoblastoma; Otros calificadores::Otros calificadores::/diagnóstico; FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación
Elsevier
Experimental Eye Research;251
https://doi.org/10.1016/j.exer.2025.110233
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3440]